nDatalyze Corp (NDAT) AI Stock Analysis

• Market Cap: C$2.07M
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): 1.69
• Revenue Growth: -100.00%
• EPS Growth: 65.85%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 41,327,423
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: 0.43
• Price to Book (P/B): 6.95
• Price to Sales (P/S): 60.55
• P/FCF Ratio: -26.32
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 47 Neutral
• Price Target: C$0.05 ▲(170.00% Upside)
• Action: Reiterated Date: 03/03/26
• Date: Action: Reiterated 03/03/26

The score is primarily weighed down by severe fundamental deterioration (collapsed revenue, persistent losses, and negative free cash flow) despite a debt-free balance sheet. Technicals provide partial support due to strong momentum above key moving averages, but overbought signals add near-term risk. Valuation remains constrained by lack of profitability and no dividend support.

Positive Factors

Debt-free balance sheet

A debt-free capital structure materially reduces near-term financing risk and interest obligations, giving management runway to restructure operations or pursue strategic options. Over 2–6 months this flexibility supports liquidity management and reduces bankruptcy risk despite operating losses.

High gross margin (2025)

An elevated gross margin indicates the company’s core product or service can generate strong unit economics if revenue returns. That structural profitability at the gross level supports scalable operating leverage and faster path to positive operating margins if top-line recovery strategies succeed.

Historic cash-flow generation

Past periods of positive operating and free cash flow demonstrate the underlying business model can be cash generative. This historical precedent provides a realistic operational blueprint for management to reallocate resources and restore self-funding capability over a multi-quarter recovery.

Negative Factors

Collapsed revenue

A multi-year collapse in revenue is a severe structural weakness: it erodes market position, destroys scale economics, and makes fixed-cost absorption impossible. Rebuilding meaningful top-line is a multi-quarter challenge and is the primary barrier to restoring profitability and growth.

Persistent negative cash flow

Sustained negative operating and free cash flow depletes liquidity and forces reliance on external funding or equity issuance. Over months this undermines investment capacity, limits product development or sales initiatives, and raises the probability of dilutive financing or asset disposals.

Eroding equity & sustained losses

A shrinking equity base driven by ongoing losses reduces the company’s capital buffer and increases solvency risk. It also weakens negotiating position with creditors and investors, constraining strategic options and making a durable recovery harder without material operational improvement or fresh capital.

nDatalyze Corp Business Overview & Revenue Model

Company Description

nDatalyze Corp (NDAT) is a technology-driven company operating in the healthcare sector. It focuses on developing innovative mental health diagnostic tools and platforms leveraging artificial intelligence and machine learning technologies. The company's core product, the YMI (Your Mental Insight) platform, aims to provide predictive insights and personalized mental health assessments to enhance mental healthcare delivery.

How the Company Makes Money

nDatalyze Corp generates revenue primarily through subscription-based access to its YMI platform. Healthcare providers, clinics, and individual users subscribe to the platform for its mental health assessment tools, which utilize advanced data analytics to offer personalized insights and recommendations. The company may also explore partnerships with healthcare organizations and technology firms to expand its market reach and enhance its service offerings. Additionally, nDatalyze may engage in research collaborations or licensing agreements to further monetize its proprietary technologies and data assets.

nDatalyze Corp Financial Statement Overview

Summary

Financial performance is very weak: revenue collapsed dramatically (2021 to 2025), losses remain substantial with extremely negative operating/net margins, and operating/free cash flow are consistently negative, indicating ongoing cash burn. The main offsetting positive is a debt-free balance sheet, but equity has been eroding due to continued losses.

Income Statement

Revenue has collapsed over time (from 662,768 in 2021 to 1,714 in 2025), and profitability has deteriorated sharply. While 2025 shows an unusually high gross margin (~91%), the company is deeply unprofitable with extremely negative operating and net margins, indicating the cost structure is not supported by the current revenue base. Losses improved versus 2023 in absolute terms, but the business remains far from breakeven and top-line momentum is the primary weakness.

Balance Sheet

The balance sheet is conservatively levered with no debt across all reported periods, which meaningfully reduces financial risk. However, equity has declined from 1,629,305 (2022) to 536,163 (2025), reflecting ongoing losses and erosion of the capital base. Returns on equity are consistently negative, so despite low leverage, the key weakness is the company’s inability to generate profits on its equity.

Cash Flow

Cash generation is weak: operating cash flow and free cash flow are negative in 2022–2025, including -466,136 of free cash flow in 2025. The business briefly generated positive operating/free cash flow in 2020–2021, but the trend reversed meaningfully, suggesting rising cash burn and reduced self-funding capacity. Free cash flow tracks net income closely (ratios near ~1), but both are negative—highlighting that losses are translating into cash outflows.

Breakdown	TTM	May 2024	May 2023	May 2022	Feb 2021	Feb 2020
Income Statement
Total Revenue	887.00	1.71K	96.34K	171.22K	424.93K	662.77K
Gross Profit	-207.00	1.55K	67.39K	44.84K	229.98K	376.73K
EBITDA	-385.56K	-636.00K	-429.24K	-1.23M	-1.17M	-688.51K
Net Income	-387.41K	-554.48K	-155.60K	-1.23M	-1.17M	-698.53K
Balance Sheet
Total Assets	525.52K	560.64K	877.91K	862.01K	1.71M	872.95K
Cash, Cash Equivalents and Short-Term Investments	499.07K	522.96K	794.10K	742.74K	1.60M	781.39K
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	23.34K	24.48K	38.26K	289.27K	81.42K	71.87K
Stockholders Equity	502.18K	536.16K	839.65K	572.74K	1.63M	801.08K
Cash Flow
Free Cash Flow	-351.19K	-466.14K	-221.64K	-1.03M	-1.14M	18.90K
Operating Cash Flow	-351.19K	-466.14K	-217.46K	-1.02M	-1.13M	20.75K
Investing Cash Flow	0.00	0.00	-4.17K	-4.39K	-13.85K	-1.84K
Financing Cash Flow	0.00	194.99K	273.00K	175.54K	1.95M	168.00K

nDatalyze Corp Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NDAT, the sentiment is Positive. The current price of 0.02 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.03, and below the 200-day MA of 0.02, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 66.68 is Neutral, neither overbought nor oversold. The STOCH value of 45.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NDAT.

nDatalyze Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	68 Neutral	C$529.88M	-185.55	1.45%	―	59.34%	-23.48%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AIDR	48 Neutral	$52.68M	-2.31	-207.53%	―	―	7.04%
NDAT	47 Neutral	C$2.07M	-4.56	-34.06%	―	-100.00%	65.85%
UDOC	46 Neutral	C$12.95M	-5.12	6239.15%	―	―	48.94%
ADK	45 Neutral	C$37.33M	-9.48	―	―	-48.53%	-9.66%

nDatalyze Corp Corporate Events

nDatalyze Plans Reverse Takeover by Alberta Mine-to-Metals Producer PRISM

nDatalyze Corp. has signed a non-binding memorandum of understanding with PRISM Diversified Ltd., an Alberta-based mine-to-metals producer, in a deal expected to result in a change of business and reverse takeover, pending regulatory and shareholder approval. The contemplated structure would see nDatalyze conduct a $1.6 million subscription receipt financing arranged by PRISM, spin out all of its current assets to pre-MOU shareholders, and leave those shareholders with a 10% stake in the post-financing resulting issuer.

The MOU also outlines that PRISM may use its own professional advisors for the reverse takeover and will cover related expenses if company advisors are used, while a bilateral break fee mechanism requires whichever party terminates to cover the other’s incurred costs plus $50,000. If completed, the transaction would effectively pivot nDatalyze’s public listing into a vehicle for PRISM’s low-emissions steel and critical minerals strategy, reshaping ownership and strategic direction for existing shareholders and positioning the combined entity within the energy-transition-focused mining sector.

The most recent analyst rating on (TSE:NDAT) stock is a Hold with a C$0.02 price target. To see the full list of analyst forecasts on nDatalyze Corp stock, see the TSE:NDAT Stock Forecast page.

nDatalyze Ends FoodCo RTO, Refocuses on Hockey Analytics App and CSE Listing

nDatalyze Corp. has terminated its proposed reverse takeover transaction with a Vancouver-based private company referred to as FoodCo, citing ongoing delays and FoodCo’s default on certain terms of their binding memorandum of understanding signed in August 2025. The company said it will continue to commercialize its Epitome hockey-focused predictive performance app, seek alternative reverse takeover candidates, and intends to apply for reinstatement of trading of its shares on the Canadian Securities Exchange, a move that may help stabilize its capital markets profile and preserve strategic flexibility following the collapse of the FoodCo deal.

The most recent analyst rating on (TSE:NDAT) stock is a Sell with a C$0.01 price target. To see the full list of analyst forecasts on nDatalyze Corp stock, see the TSE:NDAT Stock Forecast page.

nDatalyze Corp. Advances Epitome Sports Analytics Platform with Key Milestone Completion

nDatalyze Corp. has completed a significant milestone for its Epitome sports analytics platform by finalizing data collection and calibration across multiple hockey teams. This achievement validates the platform’s analytical frameworks, reducing technical risks and paving the way for market analysis and commercialization. Epitome is designed to support personalized athlete development and organizational decision-making by providing insights into factors influencing long-term performance, rather than predicting specific outcomes. The company plans to focus on market segmentation and commercialization strategies targeting specialized hockey academies, junior teams, athlete parents, and scouts.